HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael M Lederman Selected Research

Interferon-alpha (Interferon Alfa)

1/2012Interferon-alpha administration enhances CD8+ T cell activation in HIV infection.
6/2006Interferon-alpha differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael M Lederman Research Topics

Disease

66HIV Infections (HIV Infection)
01/2021 - 04/2002
43Inflammation (Inflammations)
02/2024 - 10/2010
43Infections
12/2023 - 02/2002
31Acquired Immunodeficiency Syndrome (AIDS)
01/2023 - 01/2002
18Viremia
12/2023 - 09/2003
17Disease Progression
03/2022 - 04/2002
7Cardiovascular Diseases (Cardiovascular Disease)
08/2023 - 02/2014
6Coinfection
01/2017 - 02/2003
5Atherosclerosis
12/2023 - 10/2013
5Immune Reconstitution Inflammatory Syndrome
02/2016 - 07/2010
4Atherosclerotic Plaque (Atheroma)
12/2023 - 01/2020
4Virus Diseases (Viral Diseases)
01/2017 - 01/2003
3Thrombosis (Thrombus)
07/2023 - 01/2010
3Lymphopenia (Lymphocytopenia)
01/2022 - 01/2017
3Tetanus
01/2018 - 09/2002
3Persistent Infection
06/2006 - 01/2003
2COVID-19
12/2021 - 08/2020
2Tuberculosis (Tuberculoses)
06/2021 - 01/2017
2Pneumonia (Pneumonitis)
01/2019 - 01/2002
2Fibrosis (Cirrhosis)
01/2018 - 01/2018
2Mumps
04/2013 - 05/2002
2Hepatitis C
01/2011 - 09/2007
2Opportunistic Infections (Opportunistic Infection)
06/2010 - 08/2006
2Hepatitis A (Hepatitis, Infectious)
11/2005 - 01/2003
2Hypersensitivity (Allergy)
09/2003 - 06/2003
2Hypergammaglobulinemia (Hyperimmunoglobulinemia)
09/2003 - 01/2002
1Chronic Disease (Chronic Diseases)
01/2023

Drug/Important Bio-Agent (IBA)

18CytokinesIBA
12/2023 - 01/2002
18RNA (Ribonucleic Acid)IBA
03/2019 - 04/2002
17Biomarkers (Surrogate Marker)IBA
08/2023 - 08/2013
13VaccinesIBA
02/2023 - 01/2003
12Interleukin-6 (Interleukin 6)IBA
01/2023 - 06/2010
11Lipopolysaccharide ReceptorsIBA
01/2021 - 09/2012
10AntigensIBA
01/2018 - 09/2002
8LipidsIBA
01/2023 - 09/2007
8Proteins (Proteins, Gene)FDA Link
12/2021 - 02/2003
6oxidized low density lipoproteinIBA
01/2020 - 04/2014
6fibrin fragment D (D-dimer)IBA
01/2019 - 01/2013
6Interleukin-7 (Interleukin 7)IBA
01/2017 - 06/2009
6InterferonsIBA
11/2016 - 12/2010
6Thromboplastin (Tissue Factor)IBA
11/2014 - 01/2010
6Interleukin-2 (IL2)IBA
12/2010 - 01/2003
5Antiviral Agents (Antivirals)IBA
11/2023 - 05/2002
5LigandsIBA
10/2016 - 04/2004
4C-Reactive ProteinIBA
01/2019 - 10/2013
4MaravirocFDA Link
01/2017 - 10/2010
4Raltegravir PotassiumFDA Link
01/2017 - 08/2010
4LDL CholesterolIBA
01/2017 - 10/2013
4Anti-Infective Agents (Microbicides)IBA
05/2009 - 05/2006
3Messenger RNA (mRNA)IBA
02/2023 - 11/2008
3ruxolitinibIBA
01/2023 - 12/2021
3PerforinIBA
01/2022 - 01/2003
3efavirenz (Sustiva)FDA Link
12/2021 - 10/2010
3KynurenineIBA
06/2021 - 07/2013
3Tryptophan (L-Tryptophan)FDA Link
06/2021 - 07/2013
3Interleukin-15 (Interleukin 15)IBA
01/2020 - 01/2016
3DNA (Deoxyribonucleic Acid)IBA
01/2020 - 11/2014
3Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2019 - 10/2014
3Fibrinogen (Factor I)FDA Link
01/2019 - 04/2014
31-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
01/2017 - 08/2015
3NucleosidesIBA
01/2016 - 05/2002
3LipopolysaccharidesIBA
11/2014 - 04/2009
3Interferon Type IIBA
10/2014 - 05/2009
3Peptides (Polypeptides)IBA
05/2014 - 08/2006
3Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2009 - 04/2002
3Tetanus Toxoid (Vaccine, Tetanus)FDA Link
09/2003 - 02/2002
2Granzymes (Granzyme)IBA
12/2023 - 11/2009
2CD58 Antigens (LFA-3)IBA
12/2023 - 01/2020
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2023 - 12/2010
2Fingolimod Hydrochloride (FTY720)FDA Link
01/2022 - 10/2019
2Angiotensin Receptor AntagonistsIBA
08/2020 - 01/2018
2Interferon-gamma (Interferon, gamma)IBA
01/2019 - 08/2006
2HLA-DR Antigens (HLA-DR)IBA
01/2019 - 01/2015
2EnzymesIBA
10/2016 - 08/2006
2Type I Tumor Necrosis Factor ReceptorsIBA
10/2016 - 01/2013
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2016 - 09/2007
2Reverse Transcriptase InhibitorsIBA
01/2016 - 05/2002
2Integrase InhibitorsIBA
08/2015 - 01/2015
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2015 - 06/2010
2Rosuvastatin Calcium (Crestor)FDA Link
04/2015 - 02/2014
2Chemokine ReceptorsIBA
11/2014 - 06/2003
25P12-RANTESIBA
10/2013 - 05/2009
2ChemokinesIBA
10/2013 - 11/2010
2Interferon-alpha (Interferon Alfa)IBA
01/2012 - 06/2006
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2011 - 04/2004
2InterleukinsIBA
06/2010 - 01/2003
2AntibodiesIBA
11/2005 - 02/2003
1Zidovudine (Retrovir)FDA LinkGeneric
02/2024
1mRNA VaccinesIBA
02/2023
1SARS-CoV-2 spike proteinIBA
02/2023
1BNT162 VaccineIBA
02/2023
1tocilizumab (atlizumab)FDA Link
01/2023
1Sirolimus (Rapamycin)FDA Link
01/2023

Therapy/Procedure

43Therapeutics
01/2023 - 01/2002
33Art Therapy
12/2023 - 11/2006
16Highly Active Antiretroviral Therapy (HAART)
03/2023 - 02/2002
2Transcatheter Aortic Valve Replacement
07/2023 - 01/2018
2Drug Therapy (Chemotherapy)
07/2009 - 05/2002
1Home Nursing (Nursing, Home)
02/2023
1Withholding Treatment
01/2023